Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0926 | 0.1904 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.1231 | 0.1978 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0926 | 0.1904 |
Echinococcus granulosus | bloom syndrome protein | 0.0024 | 0.1637 | 0.297 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0019 | 0.1267 | 0.2067 |
Schistosoma mansoni | lipoxygenase | 0.0054 | 0.4332 | 0.958 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.2758 | 0.2698 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.2758 | 0.5704 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0057 | 0.4518 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2671 | 0.9686 |
Schistosoma mansoni | lipoxygenase | 0.0019 | 0.1267 | 0.2672 |
Schistosoma mansoni | loxhd1 | 0.0019 | 0.1267 | 0.2672 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Brugia malayi | Doublecortin family protein | 0.0019 | 0.1267 | 0.2672 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.2758 | 1 |
Echinococcus multilocularis | bloom syndrome protein | 0.0024 | 0.1637 | 0.297 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.3869 | 0.8537 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.2507 | 0.2446 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.259 |
Brugia malayi | hypothetical protein | 0.0019 | 0.1267 | 0.2672 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.1231 | 0.259 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.2758 | 0.5704 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.1231 | 0.4295 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.0926 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0713 | 0.2362 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0036 | 0.2758 | 0.5704 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.3869 | 0.3819 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.1231 | 0.4295 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.1231 | 0.259 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.001 | 0.042 | 0.1265 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0057 | 0.4518 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0713 | 0.2362 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0036 | 0.2758 | 1 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.2758 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0006 | 0.0081 | 0.0854 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0057 | 0.4518 | 1 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0021 | 0.1385 | 1 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0057 | 0.4518 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.1267 | 0.2672 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0671 | 0.133 |
Echinococcus granulosus | RUN | 0.0019 | 0.1267 | 0.2067 |
Loa Loa (eye worm) | doublecortin family protein | 0.0019 | 0.1267 | 0.1195 |
Entamoeba histolytica | recQ family helicase, putative | 0.0013 | 0.0671 | 0.2435 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0016 | 0.0949 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0024 | 0.1637 | 0.4629 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.1231 | 0.259 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.3869 | 0.8537 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.2671 | 0.5493 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0024 | 0.1637 | 0.3507 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.1231 | 0.4295 |
Onchocerca volvulus | 0.0019 | 0.1267 | 0.5 | |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.0926 | 0.1904 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2671 | 0.9686 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.1231 | 0.1159 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0057 | 0.4518 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.001 | 0.042 | 0.0763 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.042 | 0.4422 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.2507 | 0.5467 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0926 | 0.1904 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.1231 | 0.259 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Loa Loa (eye worm) | RecQ helicase | 0.0024 | 0.1637 | 0.1569 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0036 | 0.2758 | 0.6032 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0036 | 0.2758 | 1 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0036 | 0.2758 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0057 | 0.4518 | 1 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0036 | 0.2758 | 0.5704 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.1231 | 0.268 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0926 | 0.1236 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.042 | 0.0341 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2671 | 0.9686 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.1231 | 0.4462 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0054 | 0.4332 | 0.9545 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.1267 | 0.2067 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0036 | 0.2758 | 1 |
Echinococcus multilocularis | RUN | 0.0019 | 0.1267 | 0.2067 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.2671 | 0.5493 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.1231 | 0.1978 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0019 | 0.1267 | 0.909 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.1267 | 0.2067 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.0926 | 0.1236 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0006 | 0.0081 | 0.0854 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0926 | 0.1236 |
Schistosoma mansoni | DNA helicase recq5 | 0.001 | 0.042 | 0.0763 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.2507 | 0.5467 |
Onchocerca volvulus | 0.0019 | 0.1267 | 0.5 | |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.001 | 0.042 | 0.2596 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0054 | 0.4332 | 0.9545 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.001 | 0.042 | 0.0341 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0671 | 0.2206 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.2671 | 0.9686 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0036 | 0.2758 | 1 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0713 | 0.2362 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1267 | 0.1195 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.0713 | 0.2362 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.1267 | 0.2067 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0926 | 0.1236 |
Brugia malayi | hypothetical protein | 0.0019 | 0.1267 | 0.2672 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.1231 | 0.259 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0036 | 0.2758 | 0.5704 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.1231 | 0.4295 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.1231 | 0.268 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.1231 | 0.1978 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.1267 | 0.2067 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.0926 | 0.0852 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0019 | 0.1201 | 0.2523 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.1231 | 0.1978 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.1231 | 0.4295 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.1231 | 0.1978 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.3869 | 0.3819 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1231 | 0.1159 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.1231 | 0.4295 |
Brugia malayi | hypothetical protein | 0.0036 | 0.2671 | 0.5837 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0016 | 0.0966 | 0.7461 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.1231 | 0.4295 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.2671 | 0.5837 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0036 | 0.2758 | 0.6032 |
Schistosoma mansoni | polycystin 1-related | 0.0019 | 0.1267 | 0.2672 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0926 | 0.1236 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.042 | 0.4422 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0036 | 0.2758 | 0.5704 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0053 | 0.4185 | 0.4137 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0057 | 0.4518 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.2671 | 0.5837 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.1267 | 0.1195 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0036 | 0.2758 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.0926 | 0.1236 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0019 | 0.1267 | 1 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.1267 | 0.2672 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.042 | 0.0763 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.1231 | 0.259 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.1231 | 0.259 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0024 | 0.1637 | 0.4629 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0926 | 0.0852 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.1267 | 0.2672 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.1231 | 0.259 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0006 | 0.0081 | 0.0854 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.042 | 0.0763 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0926 | 0.1904 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0013 | 0.0671 | 0.2206 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0036 | 0.2758 | 0.6032 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.1231 | 0.4295 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.0713 | 0.2362 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0019 | 0.1267 | 0.2067 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0057 | 0.4518 | 1 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0036 | 0.2758 | 0.6032 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.1231 | 0.259 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.1231 | 0.1978 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 28.5 % | Antiinflammatory activity in Swiss albino mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 60 mins before carrageenan challenge measured after 90 mins | ChEMBL. | 20116903 |
Inhibition (functional) | = 28.6 % | Antiinflammatory activity in Swiss albino mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 60 mins before carrageenan challenge measured after 270 mins | ChEMBL. | 20116903 |
Inhibition (functional) | = 29.8 % | Antiinflammatory activity in Swiss albino mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 60 mins before carrageenan challenge measured after 180 mins | ChEMBL. | 20116903 |
Inhibition (functional) | = 35.6 % | Antiinflammatory activity in Swiss albino mouse assessed as inhibition of carrageenan-induced paw edema at 100 mg/kg, po administered 60 mins before carrageenan challenge measured after 360 mins | ChEMBL. | 20116903 |
Inhibition (functional) | = 48.8 % | Analgesic activity in Swiss albino mouse assessed as p-benzoquinone-induced writhing at 100 mg/kg, po administered 60 mins before benzoquinone challenge | ChEMBL. | 20116903 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.